title: Chlamydia trachomatis vaccine research through the years.
abstract: Chlamydia trachomatis is a Gram-negative obligate intracellular bacterium. It is the leading cause of bacterial sexual transmitted infections (STIs). World Health Organization figures estimated that over 90 million new cases of genital C. trachomatis infections occur worldwide each year. A vaccination program is considered to be the best approach to reduce the prevalence of C. trachomatis infections, as it would be much cheaper and have a greater impact on controlling C. trachomatis infections worldwide rather than a screening program or treating infections with antibiotics. Currently, there are no vaccines available which effectively protect against a C. trachomatis genital infection despite the many efforts that have been made throughout the years. In this paper, the many attempts to develop a protective vaccine against a genital C. trachomatis infection will be reviewed.
authors: Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium. katelijn.schautteet@ugent.be
authors: Katelijn
authors: K
authors: Schautteet
authors: Evelien
authors: E
authors: De Clercq
authors: Daisy
authors: D
authors: Vanrompay
mesh_terms: D000818:Animals; D035843:Biomedical Research; D002690:Chlamydia Infections / Q000276:immunology / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000276:immunology*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D051379:Mice; D012290:Rickettsial Vaccines; D014614:Vaccines, Synthetic
chemical_list: D012290:Rickettsial Vaccines; D014614:Vaccines, Synthetic